ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth
NAV
₹41.4600
as of 16 Jun 2026
Expense Ratio
1.86%
AUM
₹6,565 Cr
Lumpsum returns (CAGR)
- 1Y
- +4.91%
- 3Y
- +25.43%
- 5Y
- +15.54%
- Since Inception
- +19.65%
SIP returns (XIRR)
- 1Y
- +10.42%
- 3Y
- +16.21%
- 5Y
- +18.93%
- Since Inception
- +20.74%
Beat the benchmark — ₹100/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹21,824
Benchmark
₹16,515
+₹5,309 extra wealth vs the benchmark index
Backtest this SIP yourselfSIP since inception — what ₹100/month became
Real NAV backtest from day one
₹9,500
Invested
₹21,824
Value today
20.7%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹5,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹5,000
Invested
₹20,595
Value today
19.6%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹4,75,000
Withdrawn
₹30,27,781
Corpus left
+₹25,02,781 net gain — withdrew ₹4,75,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹24,72,949
Value today
+0.1%
vs lumpsum
STP beat direct lumpsum by 0.1% — reduced timing risk paid off
Model your own STP with real NAV₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹4,65,950
Value today
4.7×
Multiple
Staying invested through that crash turned ₹1L into ₹4,65,950 — a 4.7× return
Read: Staying invested through crashesRisk Metrics
Trailing 1 year, annualised-0.04
Sharpe Ratio
+0.02
Alpha
0.37
Beta
-0.04
Sortino
15.16%
Std Dev
-16.32%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology82.00%
- Healthcare Services7.00%
- Retailing5.00%
- Insurance1.00%
- Chemicals & Petrochemicals1.00%
- Healthcare Equipment & Supplies1.00%
Each sector links to the mutual funds most exposed to it.
Thinking about ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.11.76%
- 2Cipla Ltd.8.15%
- 3Mankind Pharma Ltd.7.58%
- 4Divi'S Laboratories Ltd.6.06%
- 5Dr. Reddy'S Laboratories Ltd.5.94%
- 6Biocon Ltd.5.81%
- 7Cohance Lifesciences Ltd.4.44%
- 8Lupin Ltd.3.80%
- 9Medplus Health Services Ltd3.37%
- 10Alkem Laboratories Ltd.3.24%
Investment Objective
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹6,565 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 1.86%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations